CLINICAL_TRIALS
trial_result
· 2014-05-13
Clinical Trial Update: Study of MP0112 Intravitreal Injection in Patients With Diabetic Macular Edema [Phase 1]
Summary
A Phase 1 clinical trial of MP0112 intravitreal injection for diabetic macular edema was terminated, with results posted in May 2014.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Allergan | Conditions: Diabetic Macular Edema | Phase 1 | Status: TERMINATED | Results posted: 2014-05-13